ACHV
Achieve Life·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 3
Bearish signal 0
Consensus Rating "Buy"
Ample Liquidity
EPS Beats Expectation
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About ACHV
Achieve Life Sciences, Inc.
A late-stage clinical pharmaceutical company that develops and commercializes cytisinicline for smoking cessaton and nicotine addiction
1040 West Georgia Street, Suite 1030, Vancouver, B.C. Canada V6E 4H1
--
Achieve Life Sciences, Inc., was founded in October 1991, and OncoGenex Technologies was founded in May 2000. The Company is a clinical-stage pharmaceutical company dedicated to the global development and commercialization of cytisiniclines for smoking cessation and nicotine addiction. With more than 1 billion people using tobacco worldwide and more than 28 million adults smoking in the United States alone, smoking remains the leading cause of preventable disease and death, killing more than 8 million people worldwide each year. The company's primary focus is on responding to this global pandemic.
Earnings Call
Q1/2025
Estimate EPS-0.37
Actual EPS-0.37
Estimate Revenue--
Actual Revenue0
Contradictions Unveiled: Achieve Life Sciences' Q1 2025 Earnings Call Highlights Regulatory Challenges and Strategic Uncertainties
May 20,2025 10:58
Earnings Decrypt
Earnings Decrypt
Q2/2025
Estimate EPS-0.35
Actual EPS-0.37
Estimate Revenue--
Actual Revenue0
Contradictions Unveiled: Achieve's Q2 2025 Earnings Call Highlights FDA Review, Launch Timelines, and Pricing Strategy
Aug 07,2025 08:37
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
ACHV has released its 2025 Q3 earnings. EPS was reported at -0.28, versus the expected -0.26, missing expectations. The chart below visualizes how ACHV has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
